Novel inhibitors of the αvβ3 integrin—lead identification strategy-Reference-Cited by-同舟云学术

Novel inhibitors of the αvβ3 integrin—lead identification strategy

Published:2009-08 Issue:16 Volume:19 Page:4832-4835
ISSN:0960-894X
Container-title:Bioorganic & Medicinal Chemistry Letters
language:en
Short-container-title:Bioorganic & Medicinal Chemistry Letters

Author:

Elliot David,Henshaw Eleanor,MacFaul Philip A.,Morley Andrew D.,Newham Peter,Oldham Keith,Page Ken,Rankine Neil,Sharpe Paul,Ting Attilla,Wood Christine M.

Publisher

Elsevier BV

Subject

Organic Chemistry,Clinical Biochemistry,Drug Discovery,Pharmaceutical Science,Molecular Biology,Molecular Medicine,Biochemistry

Reference12 articles.

1. Integrins

2. Anti-Angiogenic Cancer Therapy Based on Integrin αvβ3 Antagonism

3. Involvement of αvβ3 integrins in osteoclast function

4. Integrin alpha V beta 3 as a target for treatment of rheumatoid arthritis and related rheumatic diseases

5. Ligands to the integrin receptor αvβ3

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The challenges and opportunities of αvβ3-based therapeutics in cancer: From bench to clinical trials;Pharmacological Research;2023-03

2. A new one-pot synthesis of pseudopeptide connected to sulfonamide via the tandem N-sulfonylation/Ugi reactions;New Journal of Chemistry;2021

3. Insights into Protein–Ligand Interactions in Integrin Complexes: Advances in Structure Determinations;Journal of Medicinal Chemistry;2020-01-30

4. Emergence of Small-Molecule Non-RGD-Mimetic Inhibitors for RGD Integrins;Journal of Medicinal Chemistry;2017-02-15

5. Synthesis, Characterization and Antimicrobial Activity of Bifunctional Sulfonamide-Amide Derivatives;Journal of the Korean Chemical Society;2013-12-20